JoVE Logo

Sign In

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

3.5K Views

09:54 min

May 22nd, 2020

DOI :

10.3791/61144-v

May 22nd, 2020


Explore More Videos

Natural Killer Cells

Chapters in this video

0:05

Introduction

0:27

Antibody-Mediated Activation of NK Cells

3:12

Interrogation of Signaling Molecules by Western Blot Analysis

3:47

Isolation of mRNA and Preparation for Chemokine/Cytokine Assessment

4:39

Cytoskeletal Rearrangement Assessment

5:57

Assessing Degranulation Using CD107a Surface Staining

7:10

Results: Downstream Applications of NK Cell Activation Assay

9:20

Conclusion

Related Videos

article

11:02

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

5.5K Views

article

13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

2.5K Views

article

08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

20.9K Views

article

06:53

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

3.0K Views

article

06:08

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

23.7K Views

article

Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire

2.7K Views

article

06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

18.5K Views

article

05:21

Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay

281 Views

article

11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

681 Views

article

01:22

An In Vitro Artificial Activation Assay for Studying Fc Receptor Activation by Antibodies

67 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved